Molecular Biology

CRISPR Mechanism

Bacterial immune system repurposed for gene editing — programmable DNA scissors

CRISPR-Cas9 is a programmable gene-editing system originally evolved as a bacterial immune system against viruses. Bacteria store DNA fragments from past viruses (CRISPR arrays); use them to recognize and cut viral DNA upon reinfection. Co-opted for biotech: guide RNA (matching target) directs Cas9 protein to specific DNA sequence; Cas9 cuts DNA. Cell repair: NHEJ (non-homologous end joining; introduces mutations) or HDR (homology-directed repair; precise editing). Revolutionized gene editing — fast, cheap, accurate. Nobel Prize 2020 (Charpentier, Doudna). Therapies emerging for sickle cell, β-thalassemia.

  • EtymologyClustered Regularly Interspaced Short Palindromic Repeats
  • Original functionBacterial immune system against viruses
  • ComponentsGuide RNA + Cas9 protein
  • ActionCuts target DNA at specific sequence
  • RepairNHEJ (mutation) or HDR (precise editing)
  • Nobel Prize 2020Jennifer Doudna + Emmanuelle Charpentier

Interactive visualization

Press play, or step through manually. The visualization is yours to drive — try it before reading on.

Open visualization fullscreen ↗

Watch the 60-second explainer

A condensed visual walkthrough — narrated, captioned, under a minute.

Why CRISPR matters

  • Gene editing. Programmable DNA modification.
  • Therapies. Sickle cell cure approved.
  • Research. Genetics studies accelerated.
  • Agriculture. Improved crops.
  • Diagnostics. Pathogen detection.
  • Cancer. Engineered immune cells.
  • Drug discovery. Functional genomics.

Common misconceptions

  • CRISPR is a single thing. System: gRNA + Cas9 + repair.
  • CRISPR is invented from scratch. Adapted from bacteria.
  • CRISPR perfect specificity. Off-targets exist.
  • CRISPR replaces all gene editing. Some applications need other tools.
  • CRISPR enables anything. Limited by delivery, repair efficiency.
  • CRISPR is dangerous. Safety critical; many controls developed.

Frequently asked questions

How does CRISPR-Cas9 work?

Two components. (1) Guide RNA (gRNA) — short RNA matching target DNA sequence; ~20 bases. (2) Cas9 protein — DNA endonuclease. gRNA + Cas9 form complex. Searches DNA for matching sequence. Found: Cas9 unwinds DNA; gRNA pairs with target strand; Cas9 cuts both strands. Result: double-strand break in DNA. Cell must repair the break.

What was the original CRISPR function?

Bacterial immune system. Bacteria store DNA fragments from viruses they've encountered in CRISPR arrays. When virus invades again: bacteria transcribe these into guide RNAs; combined with Cas proteins recognize and destroy viral DNA. Found in ~50% of bacteria, ~90% of archaea. Discovered 1987 (Japanese researchers); function known by 2007. Adapted for biotech ~2012.

How is editing done?

After Cas9 cut, cell repairs DSB. (1) NHEJ (Non-Homologous End Joining): default repair; often inaccurate; introduces small insertions/deletions (indels). Used for: knocking out genes (frameshift mutations destroy function). (2) HDR (Homology-Directed Repair): uses homologous template DNA; more accurate. Used for: introducing specific changes (correcting mutations). HDR is rare; most cells use NHEJ.

How specific is CRISPR?

Mostly specific but not perfect. Off-target effects: gRNA can match similar sequences. Mitigations: better gRNA design, modified Cas9 variants (high-fidelity Cas9), prime editing (more precise than CRISPR). Off-target rate varies; can be reduced. Concern for therapeutic applications: safety paramount.

What about prime editing?

Newer technique (2019). "Search and replace" without DSB. Uses Cas9 nickase fused to reverse transcriptase + extended pegRNA (prime editing guide RNA). Edits one strand at a time. Advantages: more precise, fewer off-targets, fewer indels. Can do small insertions, deletions, all 12 base substitutions. Less efficient than Cas9 but cleaner.

What therapies are CRISPR-based?

First approved (2023): Casgevy for sickle cell anemia and β-thalassemia. Patient cells extracted, edited ex vivo, infused back. Many other trials: cancer (CAR-T enhanced), HIV, hereditary blindness, muscular dystrophy. Future: directly editing inside body. Challenges: delivery, off-targets, costs.

What's the future of CRISPR?

Accelerating applications. (1) Therapy: gene corrections for genetic diseases. (2) Research: knockouts and edits in any organism. (3) Agriculture: improved crops, animals. (4) Diagnostics: SHERLOCK, DETECTR (CRISPR-based COVID detection). (5) Synthetic biology. Concerns: germline editing (heritable changes); ethical issues. Regulatory frameworks evolving.